Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1382909

registered interest
date	29/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of immunocompromised or immunosuppressed people have received (a) a Moderna third covid-19 vaccine dose and (b) the correct quantity of Moderna as a third dose.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	83308
answer	answer is ministerial correction date of answer 10/01/2022 answer text <p>The information is not held in the format requested. Whilst data for Moderna vaccine administrations is collected, information by clinical risk groups is not held centrally.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 10/01/2022 12:44:07 answering member 4447 label Biography information for Maggie Throup
tabling member	3960 label Biography information for Henry Smith

1382911

registered interest
date	29/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when covid-19 vaccine records will be amended to show third doses that have been incorrectly recorded as boosters.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	83310
answer	answer is ministerial correction date of answer 02/02/2022 answer text <p>For those who are severely immunosuppressed, the third primary COVID-19 vaccine dose is recorded as a booster vaccinations. A subsequent booster or fourth dose for eligible severely immunosuppressed patients after a further three months will be recorded as a second booster. Existing data systems support the recording of multiple boosters. All doses administered appear in an individual’s vaccination history and are recorded in the National Immunisation Management System and general practitioner record. An assessment determined that retrospectively updating or amending patient records in the immediate term could risk creating a data quality issue.</p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 83309 question first answered 02/02/2022 11:38:33 answering member 4447 label Biography information for Maggie Throup
tabling member	3960 label Biography information for Henry Smith

1365993

registered interest
date	03/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people (a) in total and (b) with blood cancer have received a third dose of their primary course of the covid-19 vaccination; and if he will publish that data on a daily basis.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	69063
answer	answer is ministerial correction date of answer 06/12/2021 answer text <p>The data requested is not available in the format requested. Daily data currently combines the total number of booster vaccinations and third primary doses, which is available at the following link:</p><p><a href="https://coronavirus.data.gov.uk/details/vaccinations" target="_blank">https://coronavirus.data.gov.uk/details/vaccinations</a></p><p>There are currently no plans to publish this data in a daily format. All individuals who have severe immunosuppression, including as a result of blood cancer, are eligible for their third primary dose of COVID-19 vaccine.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 06/12/2021 17:20:16 answering member 4447 label Biography information for Maggie Throup
tabling member	3960 label Biography information for Henry Smith

1365995

registered interest
date	03/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people who are immunosuppressed have not been offered a second dose of the covid-19 vaccine; and how many of those people have blood cancer.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	69065
answer	answer is ministerial correction date of answer 02/03/2022 answer text <p>All those with immunosuppression aged 16 years old and over living in the United Kingdom have been offered a second primary dose of COVID-19 vaccine. Immunosuppressed children aged 12 to 15 years old have also now been offered a second primary dose. The offer of first primary doses to immunosuppressed children aged five to 11 years old commenced on 31 January 2022. Vaccination data for those with blood cancer is not held in the format requested.</p><p> </p><p>As of 20 February 2022, data for those formerly regarded as clinically extremely vulnerable, which includes the immunosuppressed and those with blood cancer, shows an uptake rate of over 93.9% for a second primary dose.</p><p><strong> </strong></p> answering member constituency Erewash answering member printed Maggie Throup question first answered 02/03/2022 10:47:06 answering member 4447 label Biography information for Maggie Throup
tabling member	3960 label Biography information for Henry Smith

1343631

registered interest
date	05/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will provide an update on his plans to conduct research into the efficacy of a third covid-19 vaccine booster dose for immunocompromised and immunosuppressed groups.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	27122
answer	answer is ministerial correction date of answer 13/07/2021 answer text <p>The COV-BOOST study was commissioned through the National Institute for Health Research and will provide vital data on the impact of a third dose on patients’ immune responses. Initial findings are expected in September. To fully understand how COVID-19 vaccines respond as a booster dose they must first be studied in people with a fully functioning immune system.</p><p>UK Research and Innovation is providing £4 million towards the OCTAVE study examining COVID-19 vaccine responses in clinically at-risk groups, including immunocompromised patients.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/07/2021 15:36:39 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3960 label Biography information for Henry Smith

1293339

registered interest
date	01/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has for international collaboration on research into the covid-19 vaccine response in immunocompromised groups.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	160620
answer	answer is ministerial correction date of answer 13/04/2021 answer text <p>Our investment in the Coalition for Epidemic Preparedness Innovations (CEPI) supports ongoing vaccine research and development to respond to an evolving virus. Whilst there are no current plans for United Kingdom Government-initiated international research into the COVID-19 vaccine response on immunocompromised groups, it is important to emphasise that the research community is truly global in its collaboration and studies, those planned or published, will be shared, discussed and closely scrutinised by international researchers in this field and vice versa.</p><p>UK Research and Innovation is funding research on vaccine responses in groups of immune-suppressed individuals specifically, as part of its support for the OCTAVE study. This study includes those with inflammatory disorders, high risk cancer patient groups, and patients with severe kidney and liver disease.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/04/2021 15:29:09 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3960 label Biography information for Henry Smith

1293340

registered interest
date	01/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when second doses of the covid-19 vaccine will be administered to all clinically extremely vulnerable people; and what long term support will be provided to clinically extremely vulnerable people after the shielding deadline of the 31 March 2021.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	160621
answer	answer is ministerial correction date of answer 13/04/2021 answer text <p>By mid-February we successfully offered a first vaccine dose to everyone in the top four priority groups identified by the Joint Committee on Vaccination and Immunisation (JCVI), including clinically extremely vulnerable (CEV) individuals. The National Health Service across the United Kingdom will continue prioritising the first dose of the vaccine to those in the most high-risk groups; however, this will not interfere with everyone receiving their second dose within 12 weeks of their first. The second dose completes the course and is important for longer term protection.</p><p>As virus infection rates continue to fall, advice to CEV individuals to shield will cease from 1 April, but they must continue to follow the rules in place for everyone under the current national restrictions. Those on the shielded patient list will receive letters with updated guidance on steps people can take to reduce their risk.</p><p>Regarding longer term support for CEV individuals, local councils will continue to provide support to those in their communities in need and have systems and relationships in place with other organisations to provide that. The NHS Volunteer Responders Programme will also continue providing support with food, prescriptions and essential items to those who are self-isolating for any reason. This also includes anyone that is clinically extremely vulnerable, or anyone that is vulnerable for another reason.</p><p>Further guidance on shielding and protecting people who are clinically extremely vulnerable can be found at the following link: <a href="http://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19" target="_blank">www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/04/2021 15:26:59 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3960 label Biography information for Henry Smith

1293341

registered interest
date	01/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, which officials in his Department are responsible for deciding what support will be provided to people who are shielding during the remaining period of covid-19 restrictions.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	160622
answer	answer is ministerial correction date of answer 09/03/2021 answer text <p>Decisions on the support provided to clinically extremely vulnerable people are made by Ministers in the Department, in conjunction with other Government departments as appropriate. In doing so, Ministers are advised by the Chief Medical Officer, the Deputy Chief Medical Officers, the Scientific Advisory Group for Emergencies and other experts.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/03/2021 12:22:26 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1293342

registered interest
date	01/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how unpaid carer is defined in relation to covid-19 prioritisation; and whether that definition includes adult household members of clinically extremely vulnerable people.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	160623
answer	answer is ministerial correction date of answer 12/03/2021 answer text <p>The Green Book: chapter 14a defines adult carers as those who are eligible for a carer’s allowance, or those who are the sole or primary carer of an elderly or disabled person who is at increased risk of COVID-19 mortality and therefore clinically vulnerable. This includes unpaid carers and those who care for clinically extremely vulnerable people as a sole or primary carer. Adult carers will be prioritised for vaccination and are included in priority group six of phase one.</p><p> </p><p> </p><p>Other adult members of a household that includes someone who is clinically extremely vulnerable are, in line with the current Joint Committee on Vaccination and Immunisation advice, prioritised for vaccination according to their own age, clinical and other risk factors.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 12/03/2021 15:28:26 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3960 label Biography information for Henry Smith

1293343

registered interest
date	01/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether data is being collected on covid-19 infections and admissions among clinically extremely vulnerable people who have been vaccinated.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	160624
answer	answer is ministerial correction date of answer 09/03/2021 answer text <p>This data is not being collected in the format requested. Admissions and positive test data does not record those who are clinically extremely vulnerable or whether they have been vaccinated.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/03/2021 10:58:28 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith